Description
Aegis, like an armour, offers superb hand barrier protection and chemical resistance. Our recommended sterile glove is thicker, with an extended cuff to suit situations which require greater protection.
| REORDER CODE | SIZE |
|---|---|
| SNT154SS | Small |
| SNT154MM | Medium |
| SNT26LL | Large |
| SNT26XL | X-Large |
| MANUFACTURING ACCREDITATIONS | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 EN ISO 13485 |
| CHEMOTHERAPY DRUGS AND CONCENTRATION (TESTED FOR RESISTANCE TO PERMEATION BY CHEMOTHERAPY DRUGS AS PER ASTM D6978-05, TEST REPORT PN 138022) |
MINIMUM BREAKTHROUGH DETECTION TIME (MINUTES) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 43.8 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 97.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded an Aegis sterile nitrile glove at 43.8 minutes and 97.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |